Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Value Health. 2013 Sep-Oct;16(6):953–964. doi: 10.1016/j.jval.2013.06.014

Table 10. Monte Carlo scenarios - percentage TOLAC found cost-effective.

Cost-Effectiveness Threshold
25,000 50,000 100,000
Simulation description - variables varied
 Cerebral palsy* 100.0 100.0 100.0
 Five sensitive 68.0 68.5 69.4
 All variables without stress urinary incontinence 65.7 64.6 63.0
 Six sensitive 9.0 5.0 2.9
 Stress urinary incontinence§ 7.8 5.0 3.2
 All variables, costs 50-400% 11.8 7.3 4.6
 All variables, costs 50-150% 11.2 6.8 4.8
*

The probability, cost and disutility of cerebral palsy

The probability of uterine rupture and successful TOLAC without a prior vaginal delivery, the cost of failed TOLAC, the cost of successful TOLAC, the cost of ERCD all without complications

The probability of uterine rupture and successful TOLAC without a prior vaginal delivery, the cost of failed TOLAC, the cost of successful TOLAC, the cost of ERCD all without complications, the total frequency of stress urinary incontinence

§

The probability, cost and disutility of stress urinary incontinence